2 months ago
TEM
AnalystsTejas SavantTejas Savant's Stock Forecasts
AnalystsTejas Savant
Analyst Ranking
Bottom 7%
#4554 out of 4868 analysts
Average Return
-4.76%
Win Rate
41%41 out of 101
Risk vs Reward
Poor
Good
Tejas Savant's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Natera IncNTRA | +186.93% | $46.74 | $134.11 | 2023-11-09 - 2024-11-08 | Strong Buy |
Sophia Genetics SaSOPH | +128.65% | $1.71 | $3.91 | 2022-11-08 - 2023-11-08 | Strong Buy |
Natera IncNTRA | +97.80% | $51.02 | $100.92 | 2023-08-06 - 2024-08-06 | Strong Buy |
Avantor IncAVTR | +92.94% | $21.94 | $42.33 | 2020-09-13 - 2021-09-13 | Strong Buy |
Phenomex IncCELL | +87.74% | $5.14 | $0.63 | 2022-08-09 - 2023-08-09 | Strong Sell |
Tejas Savant Analyst Color
Get additional color on Tejas Savant's coverage of popular stocks
Tejas Savant's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avantor IncAVTR | 13 | Hold | $15.00 | +15.47% | Downgrades | 3 days ago |
Maravai Lifesciences Holdings IncMRVI | 12 | Hold | $5.00 | +147.52% | Maintains | a month ago |
Grail IncGRAL | 2 | Hold | $20.00 | -42.02% | Maintains | a month ago |
Tempus Ai IncTEM | 2 | Strong Buy | $60.00 | +16.12% | Maintains | 2 months ago |
Natera IncNTRA | 7 | Strong Buy | $185.00 | +22.57% | Maintains | 2 months ago |
10x Genomics IncTXG | 10 | Strong Buy | $26.00 | +214.39% | Maintains | 3 months ago |
Iqvia Holdings IncIQV | 10 | Strong Buy | $250.00 | +61.22% | Maintains | 3 months ago |
Illumina IncILMN | 7 | Hold | $136.00 | +75.26% | Maintains | 3 months ago |
Thermo Fisher Scientific IncTMO | 10 | Strong Buy | $678.00 | +58.04% | Maintains | 3 months ago |
Hologic IncHOLX | 8 | Hold | $82.00 | +40.89% | Maintains | 4 months ago |
Stevanato Group SpaSTVN | 1 | Hold | $23.00 | +10.26% | Assumes | 5 months ago |
Veracyte IncVCYT | 9 | Strong Sell | $28.00 | -8.20% | Maintains | 5 months ago |
Myriad Genetics IncMYGN | 2 | Hold | $21.00 | +183.40% | Maintains | 5 months ago |
Pacific Biosciences Of California IncPACB | 7 | Hold | $2.00 | +80.18% | Maintains | 9 months ago |
Akoya Biosciences IncAKYA | 7 | Hold | $3.00 | +150.00% | Downgrades | 9 months ago |
Ginkgo Bioworks Holdings IncDNA | 2 | Hold | $40.00 | +442.74% | Maintains | a year ago |
Olink Holding Ab OLK | 9 | Hold | $26.00 | N/A | Maintains | a year ago |
Cytek Biosciences IncCTKB | 7 | Hold | $7.00 | N/A | Maintains | a year ago |
Neogenomics IncNEO | 11 | Hold | $17.00 | N/A | Maintains | a year ago |
Nanostring Technologies IncNSTGQ | 8 | Hold | $8.00 | N/A | Maintains | 2 years ago |
Adaptive Biotechnologies CorpADPT | 8 | Hold | $10.00 | N/A | Maintains | 2 years ago |
Catalent IncCTLT | 9 | Strong Buy | $55.00 | N/A | Maintains | 2 years ago |
Phenomex IncCELL | 4 | Hold | $1.00 | N/A | Upgrades | 2 years ago |
Cryoport IncCYRX | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Nautilus Biotechnology IncNAUT | 3 | Hold | $6.00 | N/A | Reiterates | 2 years ago |
Sophia Genetics SaSOPH | 6 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Rapid Micro Biosystems IncRPID | 2 | Hold | $2.75 | N/A | Reiterates | 2 years ago |
Personalis IncPSNL | 3 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Seer IncSEER | 7 | Hold | $10.00 | N/A | Maintains | 2 years ago |
Guardant Health IncGH | 4 | Strong Buy | $73.00 | N/A | Maintains | 2 years ago |
Isoplexis CorpISO | 3 | Hold | $1.70 | N/A | Maintains | 2 years ago |
Cue Health IncHLTHQ | 3 | Hold | $8.00 | N/A | Maintains | 3 years ago |
Charles River Laboratories International IncCRL | 1 | Hold | $250.00 | N/A | Downgrades | 3 years ago |
Invitae CorpNVTAQ | 4 | Hold | $17.00 | N/A | Maintains | 3 years ago |
Abcam PLCABCM | 2 | Hold | $20.00 | N/A | Maintains | 3 years ago |
Biodesix IncBDSX | 2 | Hold | $11.00 | N/A | Downgrades | 3 years ago |
Ortho Clinical Diagnostics Holdings PLCOCDX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.